• Aprotinin (BPTI) for Fibrinolysis Research

  2026-09-21

  Aprotinin enables controlled, reversible interrogation of trypsin, plasmin, and kallikrein activity in fibrinolysis, inflammation, and cardiovascular surgery research. This workflow also shows how to pair protease perturbation with red blood cell membrane biophysics without mistaking an indirect biochemical effect for a direct change in membrane mechanics.

• GI 254023X: From Potency to Functional Evidence

  2026-09-21

  GI 254023X is a selective ADAM10 inhibitor for connecting target engagement with Notch1 signaling, endothelial-barrier protection, and carefully interpreted functional assays. This article uses a landmark protease-inhibition study to explain why partial pathway modulation and orthogonal readouts can outperform single endpoint experiments.

• Bafilomycin C1: From Lysosomal Mechanism to Translation

  2026-09-20

  A translational framework for using Bafilomycin C1 to connect V-ATPase biology with autophagy assays, high-content phenotyping, iPSC-derived models, and safer drug-discovery decisions.

• Aprotinin in Protease-Controlled GRO-seq Workflows

  2026-09-19

  Aprotinin adds reversible serine-protease control to workflows where proteolysis, fibrinolysis, or inflammatory signaling can confound interpretation. This guide shows how to integrate BPTI into carefully controlled sample-processing experiments while using an rRNA-depleted GRO-seq strategy to improve nascent-transcription data quality.

• Molidustat (BAY85-3934): Workflow Guide

  2026-09-18

  Molidustat (BAY85-3934) provides a practical way to interrogate HIF-PH biology, endogenous erythropoietin stimulation, and oxygen-sensing pathways in cell and biochemical assays. This guide connects renal anemia research with VHL–HIF-1α apoptosis studies while emphasizing solvent control, assay timing, and mechanistic validation.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-18

  Sulfo-NHS-LC-Biotin provides a water-compatible way to covalently biotinylate accessible primary amines on proteins, peptides, and intact cell surfaces for detection or capture. It is appropriate for stable extracellular or purified-protein labeling, but not for intracellular or reversible biotinylation workflows.

• Cell Senescence β-Galactosidase Staining Kit Guide

  2026-09-17

  Build a practical cellular senescence assay around pH 6.0 SA-β-Gal activity, with workflows for fibroblast models, senolytic screening, and frozen tissue sections. This guide combines kit-specific handling, literature-matched induction, quantitative imaging, and troubleshooting for more reproducible senescent cell detection.

• MK-571 (L-660,711): Mechanism and Uses

  2026-09-17

  MK-571, also called L-660,711, is an orally active cysLT1 receptor antagonist with nanomolar affinity and additional MRP1/ABCC1 inhibitor activity. This profile makes it useful for leukotriene-mediated inflammation research, airway pharmacology, and carefully controlled studies of macrophage drug transport.

• Forskolin for cAMP and Neuronal Reactivation

  2026-09-16

  Forskolin provides a direct route to elevated cAMP for neuronal virology, stem cell differentiation, neuroendocrine secretion, and inflammation studies. This guide connects practical dosing and formulation choices with a scalable human sensory-neuron model of HSV-1 latency and reactivation.

• TRPV1 Somatosensory Control of Inflammation

  2026-09-16

  The 2025 iScience study shows that activating TRPV1-positive sensory nerves at the nape suppresses systemic inflammation through coordinated brainstem, adrenal, vagal, sympathetic, and splenic pathways. Its combination of chemical stimulation, genetic validation, neuroendocrine measurements, and splenic RNA sequencing provides a mechanistic framework for studying somato-autonomic immune regulation.

• Tin Mesoporphyrin IX in HO Assays

  2026-09-15

  Tin Mesoporphyrin IX (chloride) enables controlled, competitive suppression of heme oxygenase for mechanistic assays spanning heme turnover, redox biology, and metabolic disease research. This guide connects a practical HO workflow with the reference study’s HO-1–ROS findings while clearly separating established evidence from proposed experimental extensions.

• Wortmannin: PI3K Inhibitor Workflow for HCC

  2026-09-15

  Wortmannin provides a practical pharmacological switch for testing how PI3K/AKT activity shapes ferroptosis resistance in hepatocellular carcinoma. This workflow connects pathway engagement, lipid peroxidation, viability, and protein biomarkers while addressing solubility, exposure, and off-target interpretation.

• Pcbp1, Mitochondria, and B Cell Immunity

  2026-09-14

  The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity in B cells. By linking Pcbp1–Fdxr regulation to complex I activity, mitochondrial reactive oxygen species, translation, IgM production, and germinal center responses, the work provides a mechanistic framework for studying how metabolism supports humoral immunity.

• TAK-715: A Selective p38 MAPK Inhibitor Workflow

  2026-09-14

  TAK-715 combines nanomolar p38α inhibition with a practical workflow for cytokine, stress-response, and rheumatoid arthritis research. Its value is greatest when pathway suppression is paired with phospho-protein, cytokine, and dephosphorylation readouts rather than relying on a single endpoint.

• Methylprednisolone Workflows for Bone Models

  2026-09-13

  Methylprednisolone gives researchers a controllable glucocorticoid challenge that connects anti-inflammatory signaling with osteoclast-driven bone damage. This guide translates macrophage, PBMC, skin, and rat osteonecrosis workflows into practical assay design, preparation, and troubleshooting decisions.

8118 records 1/542 page Next 12345 下5页 Last page